How much does molotinib cost per box

Molotinib, trade nameOjjaara, is an innovative drug used to treat myelofibrosis. This drug was developed by the British company GlaxoSmithKline and was approved by the US FDA for marketing in September 2023, bringing new treatment options to patients with specific types of blood diseases.

Molotinib is mainly used to treat intermediate or high-risk myelofibrosis, including primary and secondary types. By inhibiting specific kinase activity, it reduces the abnormal proliferation of fibrous tissue in the bone marrow and helps restore normal hematopoietic function. The drug is particularly suitable for adults with myelofibrosis who have symptoms of anemia.

Although molotinib has shown significant therapeutic efficacy, it may also be associated with some adverse reactions, such as thrombocytopenia, bleeding, bacterial infection, fatigue, dizziness, diarrhea, and nausea. Therefore, patient response needs to be closely monitored during use and appropriate adjustments made as needed.

For patients who need molotinib, since the drug is not currently available in China, they can only purchase it through overseas channels. It is understood that the original version of molotinib is available in overseas markets. Its specification is that each box contains 30 100mg tablets, and the price is approximately 220,000 yuan. At the same time, generic drugs of molotinib are also available in overseas markets, such as the version produced by Lucius in Laos. The price is much lower than the original drug and can be purchased for less than 3,000 yuan. If patients want to know more about molotinib, it is recommended to seek help from regular overseas medical consulting companies.

Overall, molotinib, as a new treatment drug, provides a more effective treatment option for patients with myelofibrosis and is expected to help patients improve their quality of life and extend their survival. However, the specific effects may vary due to individual differences, and patients are advised to use it under the guidance of a doctor.